These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9200710)

  • 1. Mechanism of DNA-dependent protein kinase inhibition by cis-diamminedichloroplatinum(II)-damaged DNA.
    Turchi JJ; Patrick SM; Henkels KM
    Biochemistry; 1997 Jun; 36(24):7586-93. PubMed ID: 9200710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Ku autoantigen binds cisplatin-damaged DNA but fails to stimulate human DNA-activated protein kinase.
    Turchi JJ; Henkels K
    J Biol Chem; 1996 Jun; 271(23):13861-7. PubMed ID: 8662830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human replication protein A preferentially binds cisplatin-damaged duplex DNA in vitro.
    Patrick SM; Turchi JJ
    Biochemistry; 1998 Jun; 37(24):8808-15. PubMed ID: 9628743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-DNA adducts inhibit translocation of the Ku subunits of DNA-PK.
    Turchi JJ; Henkels KM; Zhou Y
    Nucleic Acids Res; 2000 Dec; 28(23):4634-41. PubMed ID: 11095672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1997 Oct; 57(20):4488-92. PubMed ID: 9377558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
    Trimmer EE; Zamble DB; Lippard SJ; Essigmann JM
    Biochemistry; 1998 Jan; 37(1):352-62. PubMed ID: 9425057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential activation of DNA-PK based on DNA strand orientation and sequence bias.
    Pawelczak KS; Andrews BJ; Turchi JJ
    Nucleic Acids Res; 2005; 33(1):152-61. PubMed ID: 15640450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication protein A2 phosphorylation after DNA damage by the coordinated action of ataxia telangiectasia-mutated and DNA-dependent protein kinase.
    Wang H; Guan J; Wang H; Perrault AR; Wang Y; Iliakis G
    Cancer Res; 2001 Dec; 61(23):8554-63. PubMed ID: 11731442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication protein A (RPA) binding to duplex cisplatin-damaged DNA is mediated through the generation of single-stranded DNA.
    Patrick SM; Turchi JJ
    J Biol Chem; 1999 May; 274(21):14972-8. PubMed ID: 10329699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A targeted inhibition of DNA-dependent protein kinase sensitizes breast cancer cells following ionizing radiation.
    Kim CH; Park SJ; Lee SH
    J Pharmacol Exp Ther; 2002 Nov; 303(2):753-9. PubMed ID: 12388662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of double-strand break non-homologous end-joining by cisplatin adducts in human cell extracts.
    Diggle CP; Bentley J; Knowles MA; Kiltie AE
    Nucleic Acids Res; 2005; 33(8):2531-9. PubMed ID: 15872216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin-DNA binding specificity of calf high-mobility group 1 protein.
    Turchi JJ; Li M; Henkels KM
    Biochemistry; 1996 Mar; 35(9):2992-3000. PubMed ID: 8608137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and autoregulation of DNA-PK from structured single-stranded DNA and coding end hairpins.
    Soubeyrand S; Torrance H; Giffin W; Gong W; Schild-Poulter C; Haché RJ
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9605-10. PubMed ID: 11481441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of mammalian proteins with cisplatin-damaged DNA.
    Turchi JJ; Henkels KM; Hermanson IL; Patrick SM
    J Inorg Biochem; 1999 Oct; 77(1-2):83-7. PubMed ID: 10626358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link on the conformational and thermodynamic properties of duplex DNA.
    Pilch DS; Dunham SU; Jamieson ER; Lippard SJ; Breslauer KJ
    J Mol Biol; 2000 Feb; 296(3):803-12. PubMed ID: 10677282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione conjugate interactions with DNA-dependent protein kinase.
    Shen H; Schultz MP; Tew KD
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1101-6. PubMed ID: 10454483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible mechanism for hyperthermic radiosensitization mediated through hyperthermic lability of Ku subunits in DNA-dependent protein kinase.
    Matsumoto Y; Suzuki N; Sakai K; Morimatsu A; Hirano K; Murofushi H
    Biochem Biophys Res Commun; 1997 May; 234(3):568-72. PubMed ID: 9175753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-dependent protein kinase (DNA-PK)-dependent cisplatin-induced loss of nucleolar facilitator of chromatin transcription (FACT) and regulation of cisplatin sensitivity by DNA-PK and FACT.
    Dejmek J; Iglehart JD; Lazaro JB
    Mol Cancer Res; 2009 Apr; 7(4):581-91. PubMed ID: 19372586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II).
    Corda Y; Anin MF; Leng M; Job D
    Biochemistry; 1992 Feb; 31(7):1904-8. PubMed ID: 1536834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OK-1035, a selective inhibitor of DNA-dependent protein kinase.
    Take Y; Kumano M; Hamano Y; Fukatsu H; Teraoka H; Nishimura S; Okuyama A
    Biochem Biophys Res Commun; 1995 Oct; 215(1):41-7. PubMed ID: 7575620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.